Article Information
History
- May 6, 2024.
Article Versions
- Version 1 (May 3, 2024 - 22:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Even Moa Myklebust1,*,
- Fredrik Schjesvold2,3,
- Arnoldo Frigessi1,
- Kevin Leder4,
- Jasmine Foo5 and
- Alvaro Köhn-Luque1,6
- 1Oslo Centre for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, 0372 Oslo, Norway
- 2KG Jebsen Center for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, 0450 Oslo, Norway
- 3Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, 0450 Oslo, Norway
- 4College of Science and Engineering, University of Minnesota, Minneapolis, MN 55455, USA
- 5Institute for Mathematics and its Applications, School of Mathematics, University of Minnesota, Minneapolis, MN 55455, USA
- 6Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, 0372 Oslo, Norway
- ↵* Corresponding author; email: even.myklebust{at}gmail.com